Table 2.

A summary presents the duration of medication and the reasons why patients transitioned to surgery.

Patient	Duration of medication (months)	Reason
Patient 1	3	The unilateral cyst enlarged from 8.2 cm to 8.6 cm.
Patient 2	3	The unilateral cyst increased from 5.7 cm to 8 cm, and encapsulated effusion was discovered during surgery.
Patient 3	3	The unilateral cyst grew from 5.9 cm to 6.9 cm.
Patient 4	3	The unilateral cyst reduced from 5.7 cm to 4.7 cm in length, but pain relief was incomplete. Post-surgical pathology indicated a mucinous cystadenoma with an endometriosis background.
Patient 5	6	The bilateral cysts increased from 4.1 and 4.4 cm to 4.3 and 4.8 cm, respectively.
Patient 6	6	The unilateral cyst remained stable, changing from 6.4 cm to 6.5 cm
Patient 7	6	The unilateral cyst grew from 4 cm to 5 cm.
Patient 8	6	The unilateral cyst decreased from 4.7 cm to 4.3 cm, with unsatisfactory pain control.
Patient 9	9	The bilateral cysts increased from 3.8 and 5.1 cm to 4 cm and 5.2 cm, respectively, with the patient expressing a desire for fertility.
Patient 10	12	The unilateral cyst reduced from 4.7 cm to 4.3 cm, with the patient requesting surgery.
Patient 11	12	The unilateral cyst decreased from 5.6 cm to 3.4 cm, and encapsulated effusion was discovered, leading to surgery.